MDM2 and neoplasm: The study identified p19(ARF), a tumor suppressor, as a novel direct Stat3 target, and showed that loss of IL-6/Stat3 signaling disrupted the ARF-Mdm2-p53 tumor suppressor axis bypassing senescence and accelerating malignant progression [48].